Horizon Discovery plc Bargeld je Aktie
Was ist das Bargeld je Aktie von Horizon Discovery plc?
Bargeld je Aktie von Horizon Discovery Group plc ist 0.15
Was ist die Definition von Bargeld je Aktie?
Barmittel pro Aktie ist der Kassenbestand eines Unternehmens, geteilt durch die ausstehenden Aktien des Unternehmens.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Bargeld je Aktie von Unternehmen in Health Care Sektor auf LSE im Vergleich zu Horizon Discovery plc
Was macht Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Unternehmen mit bargeld je aktie ähnlich Horizon Discovery plc
- Northbridge Industrial Services plc hat Bargeld je Aktie von 0.15
- Canadian Pacific Railway hat Bargeld je Aktie von 0.15
- Love Global Ltd hat Bargeld je Aktie von 0.15
- Tokyo Chuo Auction hat Bargeld je Aktie von 0.15
- exactEarth hat Bargeld je Aktie von 0.15
- Wiseway hat Bargeld je Aktie von 0.15
- Horizon Discovery plc hat Bargeld je Aktie von 0.15
- National Tyre & Wheel hat Bargeld je Aktie von 0.15
- China Star Entertainment hat Bargeld je Aktie von 0.15
- i-80 Gold hat Bargeld je Aktie von 0.15
- Horizonte Minerals Plc hat Bargeld je Aktie von 0.15
- WideOpenWest Inc hat Bargeld je Aktie von 0.15
- Dunelm Plc hat Bargeld je Aktie von 0.15